secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIMI Holdings Inc. (—)
CIK:        0001213660
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001213900-22-075315
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.01
LLM model:  deepseek-v4-flash:cloud@v2

BIMI sells subsidiary Zhuoda Pharmaceutical back to former owners for 440,000 shares
--------------------------------------------------------------------------------

- Sold 100% of Chongqing Zhuoda Pharmaceutical Co., Ltd. to its former owners.
- Consideration was return of 440,000 shares of BIMI common stock previously issued.
- Transaction closed November 23, 2022; shares returned as full payment.
- Divestiture effectively reverses the prior acquisition of Zhuoda.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213660/000121390022075315/0001213900-22-075315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213660/000121390022075315/ea169309-8k_bimiinter.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-075315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer